Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 290

1.

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.

Starling AJ, André VM, Cepeda C, de Lima M, Chandler SH, Levine MS.

J Neurosci Res. 2005 Nov 1;82(3):377-86.

PMID:
16211559
[PubMed - indexed for MEDLINE]
2.

NMDA receptor function in mouse models of Huntington disease.

Cepeda C, Ariano MA, Calvert CR, Flores-Hernández J, Chandler SH, Leavitt BR, Hayden MR, Levine MS.

J Neurosci Res. 2001 Nov 15;66(4):525-39.

PMID:
11746372
[PubMed - indexed for MEDLINE]
3.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.

J Neurophysiol. 2006 Apr;95(4):2108-19. Epub 2005 Dec 28.

PMID:
16381805
[PubMed - indexed for MEDLINE]
Free Article
4.

Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene.

Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P.

Eur J Neurosci. 2001 Nov;14(9):1492-504.

PMID:
11722611
[PubMed - indexed for MEDLINE]
5.

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.

Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA.

Neuron. 2002 Mar 14;33(6):849-60.

PMID:
11906693
[PubMed - indexed for MEDLINE]
6.

Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease.

Li L, Fan M, Icton CD, Chen N, Leavitt BR, Hayden MR, Murphy TH, Raymond LA.

Neurobiol Aging. 2003 Dec;24(8):1113-21.

PMID:
14643383
[PubMed - indexed for MEDLINE]
7.

Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.

Cowan CM, Fan MM, Fan J, Shehadeh J, Zhang LY, Graham RK, Hayden MR, Raymond LA.

J Neurosci. 2008 Nov 26;28(48):12725-35. doi: 10.1523/JNEUROSCI.4619-08.2008.

PMID:
19036965
[PubMed - indexed for MEDLINE]
Free Article
8.

Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease.

Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G.

Ann Neurol. 1998 May;43(5):586-97.

PMID:
9585352
[PubMed - indexed for MEDLINE]
9.

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS.

J Neurophysiol. 2001 Dec;86(6):2667-77.

PMID:
11731527
[PubMed - indexed for MEDLINE]
Free Article
10.

Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.

Sun Z, Wang HB, Deng YP, Lei WL, Xie JP, Meade CA, Del Mar N, Goldowitz D, Reiner A.

Neurobiol Dis. 2005 Dec;20(3):907-17. Epub 2005 Jun 28.

PMID:
15990326
[PubMed - indexed for MEDLINE]
11.

Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.

Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet MF.

J Neurosci Res. 1999 Nov 15;58(4):515-32.

PMID:
10533044
[PubMed - indexed for MEDLINE]
12.

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.

Laforet GA, Sapp E, Chase K, McIntyre C, Boyce FM, Campbell M, Cadigan BA, Warzecki L, Tagle DA, Reddy PH, Cepeda C, Calvert CR, Jokel ES, Klapstein GJ, Ariano MA, Levine MS, DiFiglia M, Aronin N.

J Neurosci. 2001 Dec 1;21(23):9112-23.

PMID:
11717344
[PubMed - indexed for MEDLINE]
Free Article
13.

P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.

Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA.

Neurobiol Dis. 2012 Mar;45(3):999-1009. doi: 10.1016/j.nbd.2011.12.019. Epub 2011 Dec 14.

PMID:
22198502
[PubMed - indexed for MEDLINE]
14.

Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.

Zhang H, Li Q, Graham RK, Slow E, Hayden MR, Bezprozvanny I.

Neurobiol Dis. 2008 Jul;31(1):80-8. doi: 10.1016/j.nbd.2008.03.010. Epub 2008 Apr 16.

PMID:
18502655
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.

Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P.

J Neurochem. 2001 Aug;78(4):694-703.

PMID:
11520890
[PubMed - indexed for MEDLINE]
16.

Changes in expression of N-methyl-D-aspartate receptor subunits occur early in the R6/2 mouse model of Huntington's disease.

Ali NJ, Levine MS.

Dev Neurosci. 2006;28(3):230-8.

PMID:
16679770
[PubMed - indexed for MEDLINE]
17.

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, André VM, Cepeda C, Watson JB, Levine MS.

J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011. Epub 2011 Nov 9.

PMID:
22072510
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
[PubMed - indexed for MEDLINE]
19.

Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load.

Milnerwood AJ, Raymond LA.

J Physiol. 2007 Dec 15;585(Pt 3):817-31. Epub 2007 Oct 18.

PMID:
17947312
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.

Fernandes HB, Baimbridge KG, Church J, Hayden MR, Raymond LA.

J Neurosci. 2007 Dec 12;27(50):13614-23.

PMID:
18077673
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk